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Abstract
Background: RNA-mediated interference (RNAi)-based functional genomics is a systems-level approach to identify 
novel genes that control biological phenotypes. Existing computational approaches can identify individual genes from 
RNAi datasets that regulate a given biological process. However, currently available methods cannot identify which 
RNAi screen "hits" are novel components of well-characterized biological pathways known to regulate the interrogated 
phenotype. In this study, we describe a method to identify genes from RNAi datasets that are novel components of 
known biological pathways. We experimentally validate our approach in the context of a recently completed RNAi 
screen to identify novel regulators of melanogenesis.
Results: In this study, we utilize a PPI network topology-based approach to identify targets within our RNAi dataset 
that may be components of known melanogenesis regulatory pathways. Our computational approach identifies a set 
of screen targets that cluster topologically in a human PPI network with the known pigment regulator Endothelin 
receptor type B (EDNRB). Validation studies reveal that these genes impact pigment production and EDNRB signaling 
in pigmented melanoma cells (MNT-1) and normal melanocytes.
Conclusions: We present an approach that identifies novel components of well-characterized biological pathways 
from functional genomics datasets that could not have been identified by existing statistical and computational 
approaches.
Background
Identifying the complete set of genes that regulate a bio-
logical phenotype is a challenge of systems biology. Avail-
ability of systems-level protein-protein interaction (PPI),
gene expression, and functional genomics (FG) data has
facilitated the development of integrative computational
approaches to uncover genes involved in biological pro-
cesses [1]. Integration of C. elegans FG data [1] with exist-
ing gene expression and PPI data has facilitated the
d i s c o v e r y  o f  c o - e x p r e s s e d  g e n e  n e t w o r k s  [ 2 ] ,  e a r l y
embryogenesis control networks [3], and large-scale pro-
tein function networks [4]. Integrating Drosophila RNAi
datasets with PPI networks helped identify novel func-
tional regulators of biological phenotypes, demonstrating
that PPI networks and RNAi datasets can be effectively
integrated to derive additional functional information
from RNAi screens [5]. Application of these methods to
mammalian RNAi datasets has been more problematic
secondary to higher false positive and false negative rates
of mammalian RNAi screens [6]. Biological pathways are
distinct, experimentally-validated subnetworks of pro-
teins within the larger PPI network that interact with
each other by well defined mechanisms to regulate a spe-
cific biologic phenotype. While currently available meth-
ods can identify components of RNAi datasets that
interact with each other within PPI networks [7], no
method currently exists to determine which of these
screen "hits" are novel components of well defined path-
ways known to regulate the process under study.
Numerous studies have identified molecular determi-
nants of pigment variation: 127 mouse coat color genes
have been identified [8] that coordinately regulate the
transcription, translation, and intracellular trafficking of
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melanogenic enzymes [9]. These studies have identified
the master regulator of melanocyte transcription
microphthalmia-associated transcription factor (MITF)
[10], several melanogenic enzymes [9], and regulators of
melanosome formation and trafficking [11]. Despite
these advances, our current understanding of skin and
eye color variability is incomplete [12].
Recently, we utilized a systems-level FG platform to
identify 92 novel genes that regulate melanin production,
novel regulators of melanin secretion, and novel depig-
menting agents [13]. Notably, our approach failed to
identify many known regulators of melanogenesis among
our top tier hits, and annotation data failed to identify
connections between many screen targets and biological
pathways known to regulate melanogenesis. In this study,
we apply PPI network topology-based computational
methods to identify genes within our FG dataset that are
novel components of biological pathways known to regu-
late melanogenesis.
Results and Discussion
Topological similarity uncovers novel melanogenesis-
related regulatory network members within a functional 
genomics dataset
In this study, we examine the interrelationship between
PPI network topology and both known and newly identi-
fied biological pathways that regulate melanogenesis. In
PPI networks, nodes correspond to proteins and edges
represent possible interactions amongst them. To
increase the coverage of PPIs, we analyze the union of the
physical human PPI networks from HPRD [14], BioGRID
[15], and by Radivojac et al. [16], consisting of 47,303
interactions amongst 10,282 proteins. We characterize
the topology of nodes' neighborhoods in the PPI network
with their "graphlet degree vectors" (GDVs) [17];
graphlets are small connected induced subgraphs of a
network (Figure 1). GDV of a node, also called the node
"signature," generalizes the degree of a node that counts
how many edges the node touches into the vector of
graphlet degrees that counts how many graphlets of a
given type, such as a triangle or a square, the node
touches (see Figure 1 and additional file 1 Figure S1 for an
illustration). All 2-5-node graphlets, presented in Figure 1
and additional file 1 Figure S1, are taken into account.
Clearly, the degree of a node is the first coordinate in this
vector, since an edge (graphlet G0 in Figure 1) is the only
2-node graphlet. To take into account the symmetry
groups within a graphlet, the notion of automorphism
orbits (or just orbits, for brevity) is used for all graphlets
with 2-5-nodes. For example, it is topologically relevant
to distinguish between nodes touching a 3-node linear
path (graphlet G1 in Figure 1) at an end, or at the middle
node. By taking into account these symmetries between
nodes of a graphlet, there are 73 different orbits for 2-5-
node graphlets, numbered from 0 to 72 in Figure 1 and
additional file 1 Figure S1. Thus, GDV of a node, describ-
ing the complex topological wiring of node's up to "4-
deep neighborhood," has 73 coordinates [17]. We com-
pute pairwise "similarities" between GDVs; higher signa-
ture similarity corresponds to higher topological
similarity of the nodes' "network surroundings" (see [17]
for details). We say that two proteins are "signature-simi-
lar" if their GDV similarity is above a given threshold.
This measure has been used to demonstrate that topolog-
ically similar proteins have similar functions [17,18].
To find proteins topologically similar to known mel-
anogenesis regulators in the context of the PPI network,
we compute GDVs for pigment regulators identified in
our siRNA screen (henceforth called Screen Pigment
Regulators (SPRs)). As previous studies demonstrated
t ha t  m a n y kno wn  pigm e n t  r egula t or s ( KP Rs)  w e r e  not
present in our top tier targets but did have some impacts
o n  p i g m e n t  p r o d u c t i o n  [ 1 3 ] ,  w e  d e f i n e  S P R s  a s  g e n e s
whose siRNAs have some impact on pigment production
(Z-score < -1 or >1) (Additional File 2 Table S1). 1,244
SPRs are present in the existing PPI network. Also, the
existing PPI network contains 41 KPRs from the ESPCR
database, 10 of which are SPRs at the same time [8]. We
note that a choice of a higher Z-score threshold might be
more appropriate; however, such a choice omitted several
KPRs from the analyzed dataset and resulted in a limited
number of SPRs in the dataset that was insufficient for
any statistical analysis.
To identify specific melanogenesis regulatory subnet-
works hidden in our FG dataset, we identify SPRs with
similar GDVs in the PPI network, with the hypothesis
that some signature-similar SPRs would be components
of the same protein subnetwork. For each SPR, we form a
"cluster" containing that protein and all other proteins in
the network that are signature-similar to it (see Meth-
ods). Thus, the clusters contain proteins that have similar
topologies within the PPI network. We measure the sta-
tistical significance of SPRs to cluster together. We
denote by "hit-rate" the percentage of proteins in a cluster
that are SPRs, excluding the protein for which the cluster
was formed (see Methods and Figure 2). We find that 26
of our clusters are statistically significantly enriched with
SPRs at p-value threshold of SPR-enrichment of 0.05 (see
Methods); the list of proteins for which the clusters were
formed, together with their hit-rates and p-values, is pro-
vided in additional file 3 Table S2. By analyzing random
clusters (see Methods) and by using the same enrichment
and statistical significance criteria, we find that it is
unlikely to observe 26 statistically significantly SPR-
enriched clusters by chance (p-value = 0.009; see Meth-
ods). Note that the relatively low number of statistically
significantly SPR-enriched clusters is expected due to
incompleteness of SPR (KPR) data set. Since the numberHo et al. BMC Systems Biology 2010, 4:84
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of SPRs (KPRs) will increase in the future, it is expected
that the enrichment of each of the clusters will increase
and their p-values will decrease. Consequently, the num-
ber of statistically significantly enriched clusters will
increase as well.
By uncovering clusters that are statistically significantly
enriched with SPRs, we demonstrate that genes with
functional roles in melanogenesis indeed have similar
topological signatures in the PPI network. To determine
whether any of the SPRs are novel components of known
melanogenesis regulatory pathways, we examine clusters
of 10 SPRs that are at the same time KPRs and choose for
further analyses the cluster with the highest hit-rate. The
identified cluster is the cluster formed for EDNRB. It con-
tains 13 proteins in total and its hit-rate is 41.67%. We
analyze this cluster despite that it is not statistically sig-
nificantly SPR-enriched since (1) its hit-rate could be
considered "state of the art" given the noisiness of biolog-
ical experiments, SPR (KPR) data set, the PPI network
data that we use [18], and (2) statistically non-significant
results may be biologically and scientifically interesting
and important, whereas statistically significant results
can turn out not to be [19]. The fact that five SPRs topo-
logically cluster with EDNRB (which is both an SPR and a
KPR) and given that we have previously demonstrated the
link between topological and functional similarity
[17,18,20], we conclude that our FG dataset may contain
unappreciated members of biological pathways or sub-
networks that regulate melanogenesis. Thus, to uncover
EDNRB's corresponding melanogenesis-related pathway,
we form the "EDNRB network" by expanding in the PPI
network around the proteins in EDNRB cluster as fol-
lows. The "EDNRB network" (Figure 3) contains the set of
proteins in EDNRB cluster and their direct neighbors,
along with all interactions from the human PPI network
that exist between these nodes. There are 109 nodes in
EDNRB network (Figure 3): the proteins that are in the
cluster part of the network (i.e., are topologically similar
to EDNRB) include 2 KPRs (EDNRB, PAX2),5 SPRs
(ADRBK2, CACNA1B, GAP43, LRP8, and SPTBN2) and
6 proteins not detected by our siRNA screen (TAOK2,
DPYSL2, FHOD1, LPXN, FHL1, and STRN3); the pro-
teins that are the neighbors of the cluster proteins in the
EDNRB network include 3 KPRs (EDN3, GNA11, and
RB1), 18 SPRs (BDKRB2, AGTR1, GRK6, PTK2B, ITGA4,
DLG4, OPRM1, PLCD1, MCC, WASF1, ACTA1,
TUBA1, CELSR3, CBX4, MAPK8, MAPK8IP1, MAP2K3,
MAP2K6), and 75 proteins that are not detected by our
siRNA screen. We include direct neighbors of the cluster
proteins because the network without them is discon-
Figure 1 Graphlet degree vectors. (a) All 9 graphlets on 2, 3 and 4 nodes, denoted by G0, G1, ..., G8; they contain 15 topologically unique node types, 
called "automorphism orbits," denoted by 0, 1, 2 ..., 14. In a particular graphlet, nodes belonging to the same orbit are of the same shade [52]. (b) An 
illustration of the "Graphlet Degree Vector" (GDV), or a "signature" of node v; coordinates of a GDV count how many times a node is touched by a 
particular automorphism orbit, such as an edge (the leftmost panel), a triangle (the middle panel), or a square (the rightmost panel). Hence, the degree 
is generalized to a GDV [17]. The GDV of node v is presented in the table for orbits 0 to 14: v is touched by 5 edges (orbit 0), end-nodes of 2 graphlets 
G1 (orbit 1), etc. Values of the 73 coordinates (for all of the 30 2-5-node graphlets) of the GDV of node v are presented in Additional file 1 Figure S1.Ho et al. BMC Systems Biology 2010, 4:84
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nected. Also, since biological pathways are contiguous
"linear" structures in PPI networks, including them will
aid in detecting new members of a biological pathway.
An alternative approach to finding new pathway mem-
bers would be to consider simply an SPR and its direct
neighbors as cluster members, since it has been shown
that proteins that are closer in the network (i.e., direct
neighbors) are more likely to be functionally similar (i.e.,
involved in a same biological process) than proteins that
are further apart in the network [20]. Every cluster
defined in this way would topologically be somewhere
between a "star-like" network structure centered at the
chosen SPR (as illustrated in Additional File 4 Figure S2
that presents the EDNRB cluster obtained by this "direct
neighborhood" approach) and a fully connected network.
That is, network clusters obtained with the direct neigh-
borhood approach would have the diameter of either 1 or
2, where the diameter is defined as the maximum of
shortest path lengths between all node pairs in the net-
work. However, we tested all biological pathways from
KEGG [21] mapped onto the human PPI network to com-
pare their diameters with the diameters of the direct
neighborhood-based clusters. Due to the incompleteness
of the PPI network data, about 30% of KEGG pathways
were consisting mainly of isolated edges after they were
mapped onto the human PPI network; hence, we
removed these pathways from our analysis. For the
remaining 70% of the mapped pathways, we found that
93% of them have diameters larger than 2. The distribu-
tion of diameters of these pathways was bell-shaped, with
the average of 6.24 and the standard deviation of 2.6.
Therefore, since pathways correspond to parts of PPI net-
works that are of relatively large diameters, the simple
direct neighborhood approach is not appropriate for
finding new pathway members, since it can only produce
subgraphs of small diameters. Hence, other approaches
should be sought. In contrast, our GDV-based method
generates EDNRB network of diameter 9. Also, since
GDVs are based on all up to 5-node graphlets hence cov-
ering parts of the PPI network of diameter < 9 around an
SPR of interest, the GDV-based approach is more appro-
priate for finding new pathway members than the direct
neighborhoods.
With our GDV-based approach, in addition to the pro-
teins in the cluster formed for a given SPR, we include
into the SPR's "network" (defined above) the direct neigh-
bors of proteins in the cluster to make the network con-
nected; note that by doing so, we are indirectly taking
into account the fact that direct neighbors are more likely
to be involved in a same biological process than proteins
that are further apart in the network [20]. For compari-
son, we perform the equivalent procedure for the direct
neighborhood approach and evaluate whether this
increases the diameters of such "expanded" direct neigh-
b o r h o o d - b a s e d  s u b n e t w o r k s .  H o w e v e r ,  e v e n  i f  w e
include direct neighbors of the SPR's direct neighbors
into the cluster, the diameter of the resulting networks
would be between 1 and 4. Even if the resulting subnet-
works would have the diameter of 4, that diameter is
almost one standard deviation below the average diame-
ter of known biological pathways (which is 6.24, as stated
above). In contrast, our GDV-based approach produces
PPI subnetworks with diameters between 5 and 9, with
the average of 6.33 and the standard deviation of 1.5, thus
mimicking well the diameters of known biological path-
ways.
Validation of novel melanogenesis regulatory genes 
identified by topological clustering analysis
Topological clustering identified both SPRs and poten-
tially novel pigment regulators that are components of
the EDNRB network. As EDNRB and GNA11 siRNA
impact pigment formation in our screen and regulate
Figure 2 Application of protein interaction network topology to 
uncover novel melanogenesis gene networks from functional ge-
nomics data. Step-by-step methodology diagram is presented.Ho et al. BMC Systems Biology 2010, 4:84
http://www.biomedcentral.com/1752-0509/4/84
Page 5 of 13
melanogenesis by well-characterized mechanisms, we
next sought to experimentally validate novel EDNRB
pathway components identified by our method. EDNRB,
a g-protein coupled receptor mutated in Waardenburg-
Shah syndrome [22], binds to EDN3 [23] and activates an
intracellular signaling cascade via GNA11 [24]. Activa-
tion of EDNRB leads to PKC activation, and subsequent
ERK phosphorylation. Phosphorylated ERK can either
activate MITF by protein phosphorylation, or up-regulate
MITF transcription through CREB phosphorylation
[25,26]. MITF directly activates the expression of many
melanogenesis regulators, such as tyrosinase, the rate-
limiting enzyme in melanin synthesis [27]. In addition to
regulating melanogenesis, EDNRB plays a critical role in
neural crest development [28]. As some proteins that
interact with EDNRB may impact neural crest develop-
ment as opposed to melanogenesis, we focused on vali-
dating proteins in the EDNRB network most likely to
directly impact melanogenesis. For this analysis, we select
half of the SPRs most likely to directly regulate melano-
genesis (Z-score < -1) from Figure 3: two SPRs in the clus-
ter (EDNRB, CACNA1B), and four SPRs adjacent to the
cluster (PTK2B, AGTR1, PLCD1, OPRM1). We then vali-
date known regulators of pigmentation in our experimen-
tal system (PAX2, EDNRB, GNA11, EDN3), and examine
other proteins in the EDNRB network not identified in
our FG screen (FHOD1, DPYSL2, TAOK2, FHL1, RING1,
CXCR4).
Figure 3 EDNRB network containing proteins in the EDNRB cluster and their direct neighbors, as well as all interactions from the human 
PPI network that exist between these nodes. Known pigment regulators (KPRs) from the ESPCR database and screen pigment regulators (SPRs) are 
noted.Ho et al. BMC Systems Biology 2010, 4:84
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To experimentally validate our computational observa-
tions, we transfect MNT-1 cells with three siRNAs
directed towards each gene or control siRNAs. The abil-
ity of each target siRNA to inhibit pigment production is
compared to tyrosinase siRNA to control for the efficacy
of siRNA transfection and the background absorbance of
MNT-1 cells [13]. In this analysis, we utilize different
siRNA sequences than those used in the initial FG screen
(Additional File 3 Table S2) to further exclude any pheno-
types from the initial screen that were the result of RNAi
off-target effects. We also utilize a more robust cutoff to
identify pigment regulators (~50% normalized pigment
production) to identify only those genes with significant
impacts on pigment production. SiRNAs targeting KPRs
(EDNRB, GNA11, PAX2, EDN3) have impacts on pig-
ment production, consistent with published studies. A
majority of analyzed SPRs (86%) from EDNRB network
(PTK2B, AGTR1, PLCD1, OPRM1) have significant
impacts on pigment production observed with more than
one oligonucleotide sequence, indicating that the pheno-
types are not secondary to RNAi off-target effects (Figure
4a). Other proteins from EDNRB cluster (FHOD1,
DPYSL2, TAOK2, FHL1) have a high retest rate as well
(100%) (Figure 4a). The one gene that did not impact pig-
mentation in this analysis (CACNA1B) is a regulator of
postganglionic synaptic transmission [29], an EDNRB
neurologic phenotype independent of melanogenesis
[30]. These results demonstrate that our EDNRB network
contains newly defined regulators of pigment production
(PTK2B, AGTR1, PLCD1, OPRM1, FHOD1, DPYSL2,
TAOK2, FHL1, RING1, CXCR4).
Impact of novel EDNRB pathway components on 
downstream signaling
Our RNAi validation studies (Figure 4a) identified genes
in the EDNRB network that impact pigment production.
Based on functional annotation (Table 1), we next select
10 pigment regulators from Figure 4a to verify that these
genes impact pigment production by impacting EDNRB
signaling. Quantitative RT-PCR was utilized to determine
the impact of each siRNA on its cognate target. RT-PCR
validation studies were performed at two different time-
points to account for the potential differences in half-life
of an individual mRNA. Our validation studies revealed
that each siRNA inhibited the expression of the target
gene at either 24 or 48 hours after siRNA transfection
(Figure 4b). SiRNAs directed towards known EDNRB
pathway components (EDNRB, EDN3, and GNA11)
impact MITF protein levels, consistent with published
studies [26] (Figure 4c). Similarly, novel EDNRB pathway
components (FHOD1, TAOK1, AGTR1, RING1,
DPYSL2, PLCD1) impact MITF protein levels, suggesting
that these genes may have similar impacts on pigment
production. Activation of the EDNRB pathway leads to
increased MITF expression through p-CREB or leads to
activation of MITF protein through phosphorylation [26].
In the simplest model, genes that impact MITF phospho-
rylation will impact tyrosinase expression while genes
that impact MITF expression will impact both MITF and
tyrosinase expression. Therefore, we would predict that
siRNAs that inhibit MITF phosphorylation would have
impacts on tyrosinase expression but not MITF expres-
sion, while siRNAs that impact CREB phosphorylation
would inhibit both tyrosinase and MITF expression. To
further validate this assertion, we examine the impact of
each siRNA on the mRNA expression of MITF and tyro-
sinase. EDNRB, EDN3, and GNA11 have modest impacts
on both MITF and tyrosinase expression, as predicted.
M o s t  o f  t h e  o t h e r  s i R N A s  e x a m i n e d  i m p a c t  o n  b o t h
MITF and tyrosinase expression, with the exception of
DPYSL2 (Figure 5a).
To determine the role of individual targets in EDNRB
signaling, we examined whether the 9 genes (EDNRB,
GNA11, EDN3, FHOD1, TAOK1, AGTR1, RING1,
PTK2B, and PLCD1) that impact MITF and tyrosinase
mRNA expression also impact CREB phosphorylation.
Previous studies have determined that MNT-1 melanoma
cells contain a BRAF mutation resulting in constitutive
ERK activity [31]. Therefore, we would predict that the
majority of EDNRB pathway components that impact
pigment production in MNT-1 cells would do so via
impacts on CREB phosphorylation, as the ERK pathway
leading to MITF phosphorylation is constitutively active.
Treatment of MNT-1 cells with EDNRB, EDN3, and
GNA11 siRNAs impacts CREB phosphorylation but not
ERK phosphorylation (Figure 5b). Similarly, TAOK1,
PTK2B, FHOD1 and PLCD1 siRNAs inhibit CREB phos-
phorylation (Figure 5b). Published studies support the
notion that these four genes are components of the
EDNRB signaling network upstream of CREB phospho-
rylation. Serine/threonine-protein kinase TAO1
(TAOK1) activates the p38 MAP kinase pathway through
the specific activation of the upstream MKK3 kinase [32].
This signaling pathway activates p38 leading to CREB
phosphorylation in melanocytes [33,34]. It also is known
that Protein tyrosine kinase 2 beta (PTK2B) activation
leads to ERK1/2 activation [35]. In turn, ERK1/2 phos-
phorylates p90rsk, which phosphorylates CREB [34,36].
Endothelins promote dendrite formation facilitating mel-
anosome transport from melanocytes to keratinocytes
[37,38], processes that require extensive actin cytoskeletal
reorganization [39,40]. Formin homology 2 domain con-
taining 1 (FHOD1), a protein with several potential PKC
phosphorylation sites [41], directly binds to F-actin and
plays a role in actin cytoskeleton organization [42] and
cell elongation [43]. Additionally, FHOD1 activates ERK
inducing changes in gene expression [44]. Our studiesHo et al. BMC Systems Biology 2010, 4:84
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implicate FHOD1 as a potential player in endothelin
mediated actin-cytoskeletal reorganization.
Upon endothelins binding to endothelin receptors of
melanocytes, phospholipase C is activated [45] and initi-
ates subsequent activation of protein kinase C and ERK
pathways. Phospholipase C delta-1 (PLCD1) hydrolyzes
phosphatidylinositol 4,5-bisphosphate (PIP2) to generate
two second messengers: diacylglycerol (DG) and inositol
1,4,5-trisphosphate (IP3) [46]. DG mediates the activa-
tion of protein kinase C (PKC), and IP3 releases calcium
from intracellular stores, which in turns activate ERK
[47]. In melanocytes, PLC antagonist U73122 inhibits
endothelin-1-induced intracellular calcium rise and ERK
phosphorylation [48,49], providing direct evidence that
phospholipase C activity impacts endothelin-induced sig-
naling in primary melanocytes. Analysis of gene annota-
tion data reveals that PLCD1 is a phospholipase C
homologue that may function directly downstream of
GNA11 (Table 1). As PLC activity impacts EDNRB sig-
n a l i n g  i n  m e l a n o cy t e s ,  w e  s o u g h t  t o  e x a m i n e  w h e t h e r
PLCD1 was the PLC isoform that impacts EDNRB signal-
ing in normal melanocytes. Depletion of PLCD1 in nor-
mal melanocytes impacts MITF protein levels (Figure 5c).
Additionally, we demonstrate that PLCD1 siRNA inhibits
CREB phosphorylation in the context of EDNRB receptor
stimulation, consistent with the hypothesis that PLCD1 is
upstream of the CREB phosphorylation event. These
results demonstrate that some components in our
EDNRB network participate in EDNRB signaling in nor-
mal and cancer cells (Figure 5d).
In this study, we apply a PPI network topology-based
approach that utilizes GDVs to identify novel compo-
nents of melanogenesis regulatory pathways. Related
approaches that detect biological function from PPI net-
Figure 4 Identification of novel EDNRB network components that impact melanogenesis. (a) Genes from EDNRB network are examined for 
their impact on pigment production in MNT-1 cells. The impact of each siRNA on pigment production is calculated as described in [14] relative to 
control (c) and tyrosinase (TYR) siRNA treated cells using a normalized percent inhibition calculation. (b) Ten genes are selected from panel (a) that 
have > 50% NPI, and are not the result of siRNA off-target effects (2/3 of oligos have > 50% inhibition). The efficacy of protein knockdown for 10 pooled 
siRNAs directed towards these genes is measured by quantitative RT-PCR at both 24 and 48 hours after transfection. The timepoint where maximum 
inhibition of expression is observed is reported. AGTR1 mRNA level after siRNA treatment is below the detection limit and is not reported. Control 
siRNAs are depicted with a black bar, and target siRNAs with a white bar. *, p < 0.05. **, p < 0.01. (c) Both EDNRB and selected novel EDNRB network 
components impact the MITF protein levels in MNT-1 cells. MNT-1 cells are transfected with the indicated siRNAs for 96 hours followed by immuno-
blotting with MITF and ERK antibody as shown.Ho et al. BMC Systems Biology 2010, 4:84
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work topology rely on simpler network properties such as
direct neighbors of nodes and shortest path distances
[20,50]. Since none of the 6 SPRs in EDNRB cluster are
adjacent in the PPI network, but are at distance three or
four from each other, they could not have been topologi-
cally clustered together by analyzing only their neighbors
or distances in the PPI network. Additionally, as men-
tioned above, examining only direct neighbors of an SPR
is not appropriate for constructing its underlying melano-
genesis-related pathway.
Although GDV-based computational method has
already been used to demonstrate that topologically simi-
lar proteins share common biological properties such as
protein function or involvement in cancer [17,18], in this
paper, we provide a novel application of the method,
namely identifying novel components of biological path-
ways known to regulate melanogenesis. We use this graph
theoretic method to identify proteins with similar topo-
logical signatures to known pigment regulators and to
construct the corresponding melanogenesis-related sub-
networks. Most importantly, we experimentally validate
that the novel components of these melanogenesis-
related subnetworks are components of the EDNRB path-
way in both pigmented melanoma cells and normal mel-
anocytes.
Conclusions
In this study, we utilize a PPI network topology-based
computational approach to identify a set of novel EDNRB
pathway components. Using RNAi-based approaches, we
validate that some of the proteins in EDNRB network
impact melanogenesis, demonstrating that topological
clustering approaches can uncover additional compo-
nents of known regulatory networks. SPRs that cluster
with EDNRB have similar impacts on MITF protein lev-
els, on MITF and tyrosinase expression, and on CREB
phosphorylation, indicating that they are likely compo-
nents of the same biological pathway. Validation of
PLCD1, a potent regulator of MITF in MNT-1 cells,
reveals that novel EDNRB pathway component identified
Table 1: Annotation of genes identified in EDNRB network.
Symbol Comments Motifs Z-score
EDNRB Endothelin receptor type B. Mutation causes 
Hirschsprung disease type 2 (HSCR2) [MIM:600155]
7tm_1 -1.1
GNA11 G-protein activates phospholipase C in endothelin 
pathway
Gα -1.9
EDN3 Ligand for endothelin receptor type B EDN 0.2
PLCD1 Phospholipase produces diacylglycerol and inositol 
1,4,5-trisphosphate in endothelin pathway
PH-PLC, C2_2, EFh -1.5
TAOK1 Kinase activates the p38 MAP kinase pathway in 
endothelin pathway
SbcC, STKc_TAO -0.2
PTK2B Kinase regulates ion channel and activation of the MAP 
kinase signaling pathway in endothelin pathway
PTKc_FAK, FERM_M. Focal_AT, B41, Pkinase_Tyr -1.9
AGTR1 Receptor for angiotensin II; defect causes renal tubular 
dysgenesis (RTD) [MIM:267430]
7tm_1 -1.7
RING1 E3 ubiquitin-protein ligase for histone H2A RING-finger 0.5
FHOD1 Required for the assembly of F-actin structures FH, GBD 0.2
DPYSL2 Signaling by class 3 semaphorins and subsequent 
remodeling of the cytoskeleton
D-HYD -0.5
Gene Ontology Database is used to assess function and identify conserved domains within the corresponding proteins. Z-scores are 
calculated based on the initial screen data [14].Ho et al. BMC Systems Biology 2010, 4:84
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in MNT-1 cells impact EDNRB signaling in normal mel-
anocytes. Our study demonstrates that integration of PPI
network topology-based algorithms with functional
genomics datasets is a fruitful method to enhance our
systems-level understanding of biological phenotypes. In
the future this method may be used to place targets iden-
tified in RNAi screens within the context of known bio-
logical pathways that regulate the system under study,
Figure 5 Computationally derived EDNRB network components impact EDNRB signaling through CREB phosphorylation. (a) Novel EDNRB 
network components impact both tyrosinase and MITF expression. MNT-1 melanoma cells are transfected with pooled siRNAs and relative MITF (black 
bar) and Tyrosinase (gray bar) expression is measured by quantitative RT-PCR 96 hours after transfection. *, p < 0.05. **, p < 0.01. (b) Novel components 
of the EDNRB network impact CREB phosphorylation. Lysates from MNT-1 cells treated with the indicated pooled siRNAs are subjected to immunob-
lotting with the indicated antibodies. (c) PLCD1 impacts MITF protein levels in melanocytes. Lysates from PLCD1 siRNA transfected melanocytes are 
subjected to immunoblotting with the indicated antibodies. (d) PLCD1 impacts CREB phophorylation in normal human melanocytes. Lysates from 
melanocytes transfected with the indicated siRNAs followed by EDNRB stimulation (treatment with 10 mM Endothelin-1 for 5 minutes) are subjected 
to immunoblotting with the indicated antibodies.Ho et al. BMC Systems Biology 2010, 4:84
http://www.biomedcentral.com/1752-0509/4/84
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deriving additional relevance from systems-level RNAi
datasets.
Methods
Cell culture
MNT-1 melanoma cells were a gift of M. Marks (Univer-
sity of Pennylvania) and were cultured in DMEM (Invit-
rogen) with 15% fetal bovine serum (Hyclone), 10% AIM-
V medium (Invitrogen), 1xMEM (Invitrogen) and 1 ×
antibiotic/antimycotic (Invitrogen). Darkly pigmented
human neonatal epidermal melanocytes (Cascade Biolog-
ics) were cultured in Medium 254 with the melanocyte
specific HMGS supplement (Cascade Biologics) and 0.1
mM 3-Isobutyl-1-methylxanthine (IBMX).
Protein clustering via topological similarity measure
In our study, we focus on proteins with more than three
interacting partners in the PPI network, since poorly con-
nected proteins are more likely to reside in incomplete
parts of PPI networks [17,18]. However, to account for
the entire topology of the PPI network, when GDVs are
computed, all proteins and interactions in the PPI net-
work are taken into account. There are 5,423 proteins
with degrees higher than three in the network, out of
which 1,244 are SPRs, and 41 are KPRs contained in the
ESPCR database [8]; 10 SPRs are KPRs at the same time.
The code for computing GDVs [17] is available in Graph-
Crunch [51], an open source software tool for large net-
work modeling and analyses.
We perform the GDV-based clustering as follows: for
each of the 1,244 SPRs with degrees greater than 3 in the
PPI network, we identify a cluster containing that protein
and all other proteins in the network having degrees
higher than 3 that are topologically similar to it, i.e., that
have GDV similarities with the protein of interest above a
threshold; thresholds between 90% and 95% have been
used previously [17]. We find the highest threshold at
which a node is clustered with at least one more node by
performing the following: (1) we initially set the signature
similarity threshold to 96%; (2) if the SPR for which the
cluster is formed is signature-similar with at least one
more node at the given threshold, we create the cluster
containing these nodes and the SPR; (3) if a protein of
interest is not signature-similar with any other protein at
a given threshold, we decrease the threshold and repeat
steps 2 and 3; (4) we stop the clustering process for a
given SPR when its cluster has been formed; we decrease
the threshold down to 90% searching for non-empty clus-
ters, but not below 90%; if a protein is not signature-simi-
lar with any other protein at the lowest threshold of 90%,
we do not form a cluster for that protein. We try to form
clusters for all 1,244 SPRs. However, 263 of them are not
90% signature similar to any other nodes in the PPI net-
work. Additional 237 of them cluster only with one other
node. Thus, we analyze clusters of size 3 or more formed
for 743 SPRs. The minimum threshold of 90% for signa-
ture similarity was chosen because it has been empirically
shown that for higher thresholds, only a few small clus-
ters are obtained, indicating too high stringency in signa-
ture similarities, whereas for lower thresholds, clusters
are very large, indicating a loss of signature similarity
[17].
In each cluster formed in this fashion, we measure the
enrichment of SPRs. We define the "hit-rate" of a cluster
as the percentage of proteins in the cluster that are SPRs,
excluding the protein of interest. We also compute the
statistical significance of observing a given hit-rate in the
cluster, measuring the probability that the cluster is
enriched by a given number of SPR proteins purely by
chance. This probability (p-value) is computed as follows.
The total number of proteins in the PPI network with
degrees higher than 3 is N = 5,422 (excluding the SPR for
which the cluster was formed) and there are S = 1,243
SPRs with degrees higher than 3 (excluding the SPR for
which the cluster was formed). We use the following
notation: the size of a cluster of interest is C, excluding
the protein for which the cluster was formed; the number
of proteins in the cluster that are SPRs is k, excluding the
protein for which the cluster was formed. The hit-rate of
the cluster is k/|C|, and the p-value for the cluster, i.e., the
probability of observing the same or higher hit-rate
purely by chance is:
Depending on a method and its application, sensible
cut-offs for p-values were reported to range from 10-2 to
10-8 [52]. We find that 26 out of 743 clusters formed for
SPRs are enriched with SPRs with p-values of SPR enrich-
ment below 0.05. Since we perform statistical testing on
743 clusters, we believe that the reported p-values do not
need to be corrected for multiple testing.
Given that 26 of our clusters are statistically signifi-
cantly SPR-enriched at p-value threshold of 0.05, we
compute the probability of observing 26 statistically sig-
nificantly SPR-enriched clusters by chance (i.e., statistical
significance). For each of the 743 SPRs, we create "ran-
d o m "  c l u s t e r s  o f  t h e  s a m e  s i z e  a s  t h e  c o r r e s p o n d i n g
GDV-based clusters. Then, we measure statistical signifi-
cance of SPR enrichment in these random clusters. Since
the clusters are random, we repeat the randomization
procedure 1,000 times. We find that only in 9 out of the
1,000 runs, 26 or more clusters are statistically signifi-
cantly enriched with SPRs, leading to empirical (fre-
pv a l u e
S
i
NS
Ci
N
C
i
k
−= −
⎛
⎝
⎜
⎞
⎠
⎟
−
−
⎛
⎝
⎜
⎞
⎠
⎟
⎛
⎝
⎜
⎞
⎠
⎟
=
− ∑ 1
0
1Ho et al. BMC Systems Biology 2010, 4:84
http://www.biomedcentral.com/1752-0509/4/84
Page 11 of 13
quency) probability of 0.009 for observing 26 or more
statistically significantly SPR-enriched clusters by chance.
Furthermore, since the distribution of the number of sta-
tistically significantly SPR-enriched random cluster over
the 1,000 runs is bell-shaped, we use the formula for com-
puting Z-score to standardize our observation in the data
of having 26 statistically significantly SPR-enriched clus-
ters. Then, we use the normal distribution table to com-
pute the p-value corresponding to the resulting Z-score.
If we denote by x = 26 the raw score to be standardized,
by μ= 15.45 the mean of the (random) population, i.e., the
average over the 1,000 runs of the number of random
clusters that are statistically significantly SPR-enriched,
and by σ = 4.03 the standard deviation over the 1,000
runs, we get Z-score of 2.62. Using the normal distribu-
tion table, we find that this Z-score corresponds to the p-
value of 0.0044; that is, in this way, we find that the prob-
ability of observing 26 or more statistically significantly
SPR-enriched clusters at random is lower than 0.0044.
SiRNA transfection
For western blot analysis, 6 × 104 MNT-1 cells were trans-
fected with 75 nM pooled siRNAs using a Dharmafect-2
transfection reagent as previously described [13]. Simi-
larly, 6 × 104 melanocytes were transfected with 12.5 nM
pooled siRNAs (two) toward each gene using a HiPerFect
transfection reagent as previously described [13]. For pig-
ment measurement, 1 × 104 MNT-1 cells were trans-
fected with 8 nM pooled siRNAs (two siRNAs) using a
Dharmafect-2 transfection reagent as described. We per-
formed each transfection in triplicate. For RT-qPCR, we
used 4 × 103 MNT-1 cells in the same 96-well format. We
obtained pooled siRNAs for tyrosinase from Dharmacon,
and all the other siRNAs from Ambion. A list of all siRNA
sequences are contained in Additional File 5 Table S3.
Pigment measurement and data normalization
For pigment measurement, we transfected MNT-1 cells
with the corresponding siRNA in 96 well plates and incu-
bated them for 120 hours at 37°C/5% CO2. Subsequently,
we removed 100 ul of the medium from each well and
added 15 ul of CellTiter-Glo Reagent (CTG) (Promega) to
each well according to the manufacturer's protocol. We
measured luminescence and absorbance at 405 nm for
each well of the 96 well plate using a DTX800 Multimode
Detector (Beckman Coulter). We normalized absorbance
values with raw luminescence values that are propor-
tional to cell number to determine relative pigment per
cell. We calculated a normalized percent inhibition from
these values to account for the background absorbance of
MNT-1 cells and variability in transfection. Normalized
percent inhibition (NPI) = [(Pigment Index non-targeting con-
trol siRNA -Pigment Index sample)/(Pigment Index non-targeting
control -Pigment Index tyrosinase siRNA)] × 100%. We use a
student's t-test to calculate the p-values of each sample
v.s. non-targeting control.
Immunoblotting
For our immunoblotting experiments, MNT-1 cells 96
hrs post-transfection and melanocytes 144hrs post-trans-
fection were lysed in RIPA buffer supplied with proteases
inhibitors cocktail, PMSF and sodium orthovanadate
(Santa Cruz Biotechnology). For experiments in melano-
cytes looking at downstream EDNRB signaling, we
treated melanocytes with 10 μM Endothelin-1 for 5mins.
After boiling with sample buffer, we loaded the samples
to 4-20% SDS-PAGE and subjected them to western blot-
ting with anti-MITF (C5, Santa Cruz Biotechnology),
anti-phospho-ERK1/2 (Cell Signaling Technologics),
anti-phospho-CREB (Cell Signaling Technologics), anti-
alpha/beta-tubulin (Cell Signaling Technologics) and
anti-beta-actin (Cell Signaling Technologics) antibodies.
Quantitative RT-PCR
96hrs after siRNA transfection, we prepared cDNA from
MNT-1 cells using a Cells-to-Ct kit (Ambion) according
to the manufacterer's protocol. For measurement of
siRNA knockdown efficiency, we prepared cDNA from
MNT-1 cells 48 hrs after transfection for most of the
genes except RING1, FHOD1, TAOK1 at 24 hrs to cap-
ture the impact in different mRNA kinetics. We added an
aliquot of each cDNA reaction to each Taqman master
mix reaction along with the appropriate primer and
probe set purchased from Applied Biosystems per the
manufacturer's protocol (Applied Biosystems). Primers
and probes sequences are listed in Additional File 6 Table
S4. We utilized a 7900HT Fast Real-Time PCR System
(Applied Biosystems) to determine Ct values. We normal-
ized values by human beta-actin Ct values and analyzed
our data using the relative quantification mathematical
model (Pfaffl).
Additional material
Additional file 1 Figure S1: (a) All 30 graphlets on 2 to 5 nodes; they 
contain 73 topologically unique node types, called "automorphism 
orbits". In a particular graphlet, nodes belonging to the same orbit are of 
the same shade [52]. (b) An illustration of the "Graphlet Degree Vector" 
(GDV), or a "signature" of node v; coordinates of a GDV count how many 
times a node is touched by a particular automorphism orbit, such as an 
edge (the leftmost panel), a triangle (the middle panel), or a square (the 
rightmost panel). Hence, the degree is generalized to a GDV [17]. The GDV 
of node v is presented in the table for orbits 0 to 72: v is touched by 5 edges 
(orbit 0), end-nodes of 2 graphlets G1 (orbit 1), etc.
Additional file 2 Table S1: siRNAs from our genome wide siRNA 
screen with Z-score < -1 or > 1.
Additional file 3 Table S2: Proteins that form the cluster.
Additional file 4 Figure S2: EDNRB cluster obtained by considering its 
direct neighbors in the PPI network. Unlike the EDNRB network obtained 
with our GDV-based approach, this network is clearly a star-like network 
structure centered around EDNRB. This structure is unlikely to represent a 
biological pathway, since its diameter, defined as the maximum of shortest 
path distances between all node pairs in the network, is 2, whereas we find 
that about 93% of real human biological pathways from KEGG [21], when 
mapped onto the human PPI network, have diameters larger than 2, with 
the average of 6.24 and the standard deviation of 2.6.
Additional file 5 Table S3: siRNA sequences used in this study.
Additional file 6 Table S4: qPCR probe sequences used in this study.Ho et al. BMC Systems Biology 2010, 4:84
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Abbreviations
RNAi: RNA-mediated interference; siRNA: small interfering RNA; RT-PCR:
reverse-transcription polymerase chain reaction; PPI: protein-protein interac-
tion; FG: functional genomics; EDNRB: Endothelin receptor type B; MITF:
microphthalmia-associated transcription factor; SPR: screen pigment regulator;
KPR: known pigment regulator; GDV: graphlet degree vector; CREB: cAMP
response element binding; ERK: extracellular signal-regulated kinase.
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